These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16564577)

  • 1. T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients.
    Satoh J; Nakanishi M; Koike F; Onoue H; Aranami T; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Saito T; Ohta M; Miyake S; Kanda T; Fukazawa T; Yamamura T
    J Neuroimmunol; 2006 May; 174(1-2):108-18. PubMed ID: 16564577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferon -beta therapy in multiple sclerosis].
    Satoh J
    Nihon Rinsho; 2006 Jul; 64(7):1297-309. PubMed ID: 16838648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis.
    Satoh J; Nakanishi M; Koike F; Miyake S; Yamamoto T; Kawai M; Kikuchi S; Nomura K; Yokoyama K; Ota K; Kanda T; Fukazawa T; Yamamura T
    Neurobiol Dis; 2005 Apr; 18(3):537-50. PubMed ID: 15755681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic effects of once-weekly, intramuscular interferon-beta1a treatment after the first dose and on chronic dosing: Relationships to 5-year clinical outcomes in multiple sclerosis patients.
    Weinstock-Guttman B; Bhasi K; Badgett D; Tamaño-Blanco M; Minhas M; Feichter J; Patrick K; Munschauer F; Bakshi R; Ramanathan M
    J Neuroimmunol; 2008 Dec; 205(1-2):113-25. PubMed ID: 18950872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to disease.
    Bomprezzi R; Ringnér M; Kim S; Bittner ML; Khan J; Chen Y; Elkahloun A; Yu A; Bielekova B; Meltzer PS; Martin R; McFarland HF; Trent JM
    Hum Mol Genet; 2003 Sep; 12(17):2191-9. PubMed ID: 12915464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of MxA induction by interferon beta in patients with MS reflects complete loss of bioactivity.
    Hesse D; Sellebjerg F; Sorensen PS
    Neurology; 2009 Aug; 73(5):372-7. PubMed ID: 19652141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression changes in peripheral blood mononuclear cells from multiple sclerosis patients undergoing beta-interferon therapy.
    Singh MK; Scott TF; LaFramboise WA; Hu FZ; Post JC; Ehrlich GD
    J Neurol Sci; 2007 Jul; 258(1-2):52-9. PubMed ID: 17467740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity.
    Achiron A; Gurevich M; Friedman N; Kaminski N; Mandel M
    Ann Neurol; 2004 Mar; 55(3):410-7. PubMed ID: 14991819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of relevant biomarkers for treatment evaluation in multiple sclerosis.
    Hong J; Zang YC; Hutton G; Rivera VM; Zhang JZ
    J Neuroimmunol; 2004 Jul; 152(1-2):126-39. PubMed ID: 15223245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.
    Bustamante MF; Fissolo N; Río J; Espejo C; Costa C; Mansilla MJ; Lizasoain I; Moro MA; Carmen Edo M; Montalban X; Comabella M
    Ann Neurol; 2011 Oct; 70(4):634-45. PubMed ID: 22028223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression analysis of interferon-beta treatment in multiple sclerosis.
    Sellebjerg F; Datta P; Larsen J; Rieneck K; Alsing I; Oturai A; Svejgaard A; Soelberg Sørensen P; Ryder LP
    Mult Scler; 2008 Jun; 14(5):615-21. PubMed ID: 18408020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MxA protein induction in MS patients treated with intramuscular IFNbeta-1a.
    Vallittu AM; Salmi AA; Erälinna JP;
    Neurol Sci; 2006 Feb; 26(6):438-43. PubMed ID: 16601938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular biomarkers for prediction of multiple sclerosis relapse].
    Satoh J
    Nihon Rinsho; 2008 Jun; 66(6):1103-11. PubMed ID: 18540355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course transcriptomics of IFNB1b drug therapy in multiple sclerosis.
    Serrano-Fernández P; Möller S; Goertsches R; Fiedler H; Koczan D; Thiesen HJ; Zettl UK
    Autoimmunity; 2010 Mar; 43(2):172-8. PubMed ID: 19883335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic activities of intravenous immunoglobulins in multiple sclerosis involve modulation of chemokine expression.
    Pigard N; Elovaara I; Kuusisto H; Paalavuo R; Dastidar P; Zimmermann K; Schwarz HP; Reipert B
    J Neuroimmunol; 2009 Apr; 209(1-2):114-20. PubMed ID: 19217671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFNbeta therapy progressively normalizes the increased ex vivo T lymphocyte apoptosis observed in active patients with multiple sclerosis.
    García-Merino A; Barcenilla H; Díaz D; Monserrat J; Prieto A; Alvarez-Mon M;
    Clin Immunol; 2009 Aug; 132(2):195-202. PubMed ID: 19443275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.
    Byun E; Caillier SJ; Montalban X; Villoslada P; Fernández O; Brassat D; Comabella M; Wang J; Barcellos LF; Baranzini SE; Oksenberg JR
    Arch Neurol; 2008 Mar; 65(3):337-44. PubMed ID: 18195134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological response genes after single dose administration of interferon beta-1b to healthy male volunteers.
    Hilpert J; Beekman JM; Schwenke S; Kowal K; Bauer D; Lampe J; Sandbrink R; Heubach JF; Stürzebecher S; Reischl J
    J Neuroimmunol; 2008 Aug; 199(1-2):115-25. PubMed ID: 18565596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon receptor expression in multiple sclerosis patients.
    Oliver B; Mayorga C; Fernández V; Leyva L; León A; Luque G; López JC; Tamayo JA; Pinto-Medel MJ; de Ramon E; Blanco E; Alonso A; Fernández O
    J Neuroimmunol; 2007 Feb; 183(1-2):225-31. PubMed ID: 17188754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.